Trump’s cannabis order signals a medical reckoning that could redefine recovery, research, and athlete care. Continue reading Trump’s Cannabis Reset: A Schedule III Shift That Could Redefine Medicine, Sports, and Recovery
An American athlete avoided execution, but the case underscores an urgent failure in international athlete protection. Continue reading Jarred Shaw’s Sentence Exposes the Global Collision Between Cannabis Medicine and Zero-Tolerance Drug Laws
California’s legal cannabis industry is bracing for impact as a new 19% excise tax threatens to widen the gap between legal and illicit markets. With athletes and health professionals relying on cannabis for performance and recovery, the tax hike could have major implications for sports wellness, innovation, and market sustainability. Continue reading California’s Cannabis Industry Takes Another Hit at the Buzzer: New Tax Hike Threatens the Legal Playbook
In a groundbreaking development, the Drug Enforcement Administration (DEA) has announced its recommendation to reclassify cannabis under federal law, marking a significant shift in drug policy. Continue reading DEA’s Historic Move: Cannabis Reclassification Sparks Debate on the Future of Drug Policy and Wellness
On Friday, January 12, 2024, the United States Government released documents confirming the Department of Health and Human Services has recommended the Drug Enforcement Agency (DEA) to reschedule cannabis as Schedule III under the Controlled Substances Act. Continue reading It’s Official, The Feds Finally Release Documents Confirming the Recommendation To Reschedule Cannabis
SPORTS CANNABIS 